MyFinsight
Home
Blog
About
Contact
Download
Download image
Accounts receivable, net
of allowance for...
$48,529,574
Inventory
$25,099,135
Cash
$21,094,904
Prepaid expenses and
other current assets
$2,066,258
Property and equipment,
gross
$27,883,555
Restricted cash - debt
service for njeda bonds
$467,575
Security deposits
$91,981
Total current assets
$96,789,871
Deferred income tax asset
$10,325,353
Property and equipment,
net of accumulated...
$10,035,389
Intangible assets
$5,637,802
Operating lease -
right-of-use asset
$1,651,592
Finance lease -
right-of-use asset, net of...
$1,413,074
Total other assets
$559,556
Less accumulated
depreciation
$17,848,166
Total assets
$126,412,637
Total liabilities and
shareholders equity
$126,412,637
Total shareholders
equity
$80,314,083
Total liabilities
$46,098,554
Accumulated deficit
-$94,292,428
Treasury stock 100,000
shares as of both...
$306,841
Additional paid-in capital
$173,838,752
Total long-term
liabilities
$32,911,375
Total current
liabilities
$13,187,179
Common stock par value
0.001 1,445,000,000...
$1,074,600
Derivative financial
instruments - warrants
$27,971,706
Loans payable, net of
current portion
$2,176,938
Lease obligation -
operating lease, net of...
$1,157,161
Lease obligation -
finance lease, net of...
$957,555
Bonds payable, net of
current portion and bond...
$648,015
Accounts payable
$6,522,108
Accrued expenses
$5,547,783
Lease obligation -
operating lease, current...
$519,739
Lease obligation -
finance lease, current...
$370,047
Bonds payable,
current portion, net of...
$135,822
Loans payable,
current portion
$91,680
Back
Back
Balance Sheet
source: myfinsight.com
ELITE PHARMACEUTICALS INC NV (ELTP)
ELITE PHARMACEUTICALS INC NV (ELTP)